Recurrent Atrial Fibrillation: Clinical Trials

3 trials for Recurrent Atrial Fibrillation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1

Follow Recurrent Atrial Fibrillation: new trials by email Literature Review of Recurrent Atrial Fibrillation trials Research Report on Recurrent Atrial Fibrillation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation
Atrioventricular junction ablation in patients with cardiac resynchronization therapy (CRT), Optimal medication treatment in patients with cardiac resynchronization therapy (CRT) - Recurrent Atrial Fibrillation, Persistent Atrial Fibrillation
Not applicableRecruitingUniversity Hospital Ostrava4802023-04-012023-06-08
AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation
AcQMap Imaging and Mapping System - Recurrent Atrial Fibrillation
Not applicableCompletedAcutus Medical1282018-04-122022-07-27
Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation
AVATAR-AF ablation, Anti-Arrhythmic therapy, Conventional AF ablation - Heart Failure, Recurrent Atrial Fibrillation
Not applicableCompletedImperial College London3212015-05-012024-10-09

Narrower conditions

Atrial Fibrillation (3)  ·  Heart Failure (1)

Broader conditions

Arrhythmias, Cardiac (3)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)

Interventions

Adrenergic beta-Antagonists (1)  ·  Amiodarone (1)  ·  Calcium Channel Blockers (1)  ·  Cardiac Resynchronization Therapy (1)  ·  Flecainide (1)  ·  Propafenone (1)  ·  Sotalol (1)

Sponsors

Acutus Medical (1)  ·  Imperial College London (1)  ·  University Hospital Ostrava (1)

Countries

Czechia (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Canada (1)  ·  Germany (1)  ·  Netherlands (1)

Top investigators

Andrew Grace, MD (1)  ·  Dr. Prapa Kanagaratnam (1)

Results publications

PMID 31152874, PMID 36576323